Do leukotriene receptor antagonists have a place in pharmacotherapy of allergic rhinitis?
Nathan
Robert A
RA
D000085:Acetates / Q000008:administration & dosage*; D000281:Administration, Intranasal; D000284:Administration, Oral; D000730:Androstadienes / Q000008:administration & dosage*; D018926:Anti-Allergic Agents / Q000008:administration & dosage*; D003521:Cyclopropanes; D000068298:Fluticasone; D006801:Humans; D020024:Leukotriene Antagonists / Q000008:administration & dosage*; D017336:Loratadine / Q000008:administration & dosage; D011804:Quinolines / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D013440:Sulfides
D000085:Acetates; D000730:Androstadienes; D018926:Anti-Allergic Agents; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; D017336:Loratadine; D000068298:Fluticasone; C093875:montelukast